Log in

Evolent Health Stock Forecast, Price & News

+0.62 (+4.26 %)
(As of 11/27/2020 12:00 AM ET)
Today's Range
Now: $15.19
50-Day Range
MA: $11.93
52-Week Range
Now: $15.19
Volume598,905 shs
Average Volume1.31 million shs
Market Capitalization$1.30 billion
P/E RatioN/A
Dividend YieldN/A
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; delivery network alignments; and integrated cost and revenue management solutions. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. The company was founded in 2011 and is headquartered in Arlington, Virginia.
Read More
Evolent Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.23 out of 5 stars

Industry, Sector and Symbol

Industry Management services



Sales & Book Value

Annual Sales$846.38 million
Cash Flow$3.27 per share
Book Value$10.98 per share


Net Income$-301,970,000.00


Market Cap$1.30 billion
Next Earnings Date2/23/2021 (Estimated)
+0.62 (+4.26 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EVH News and Ratings via Email

Sign-up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Evolent Health (NYSE:EVH) Frequently Asked Questions

How has Evolent Health's stock been impacted by Coronavirus (COVID-19)?

Evolent Health's stock was trading at $6.92 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, EVH stock has increased by 119.5% and is now trading at $15.19.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Evolent Health?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Evolent Health
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Evolent Health?

Wall Street analysts have given Evolent Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Evolent Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Evolent Health's next earnings date?

Evolent Health is scheduled to release its next quarterly earnings announcement on Tuesday, February 23rd 2021.
View our earnings forecast for Evolent Health

How were Evolent Health's earnings last quarter?

Evolent Health, Inc. (NYSE:EVH) posted its earnings results on Thursday, November, 5th. The technology company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.10. Evolent Health had a negative return on equity of 4.68% and a negative net margin of 53.56%.
View Evolent Health's earnings history

What guidance has Evolent Health issued on next quarter's earnings?

Evolent Health updated its FY 2020 After-Hours earnings guidance on Thursday, November, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1-1.014 billion, compared to the consensus revenue estimate of $1.02 billion.

What price target have analysts set for EVH?

11 Wall Street analysts have issued 1 year price targets for Evolent Health's shares. Their forecasts range from $8.00 to $20.00. On average, they expect Evolent Health's share price to reach $13.38 in the next twelve months. This suggests that the stock has a possible downside of 11.9%.
View analysts' price targets for Evolent Health

Who are some of Evolent Health's key competitors?

What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX).

Who are Evolent Health's key executives?

Evolent Health's management team includes the following people:
  • Mr. Frank John Williams, Co-Founder & Exec. Chairman (Age 54, Pay $903k)
  • Mr. Seth Barrie Blackley, Co-Founder, CEO & Director (Age 41, Pay $652.67k)
  • Mr. John Paul Johnson, Chief Financial Officer (Age 36, Pay $451.67k)
  • Mr. Jonathan David Weinberg, Chief Legal Officer, Gen. Counsel & Sec. (Age 52, Pay $652.33k)
  • Dr. Norman C. Payson, Advisor (Age 71, Pay $200k)
  • Mr. Nicholas McGrane, Exec. VP of Corp. Performance (Age 52, Pay $508.75k)
  • Mr. Steve Tutewohl, Chief Operating Officer (Age 48)
  • Mr. Aammaad Shams, Interim Principal Accounting Officer & Corp. Controller (Age 36)
  • Mr. Bob East, Investor Contact
  • Ms. Jordan Flynn, VP & Chief Compliance Officer

When did Evolent Health IPO?

(EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include JPMorgan Chase & Co. (7.77%), BlackRock Inc. (6.17%), State Street Corp (2.04%), Peregrine Capital Management LLC (1.09%), Arrowstreet Capital Limited Partnership (1.08%) and Great Lakes Advisors LLC (0.98%). Company insiders that own Evolent Health stock include Doug S Aron, Jonathan Weinberg, Kenneth A Samet, Michael D'amato and Seth Blackley.
View institutional ownership trends for Evolent Health

Which major investors are selling Evolent Health stock?

EVH stock was sold by a variety of institutional investors in the last quarter, including BNP Paribas Arbitrage SA, BlackRock Inc., Peregrine Capital Management LLC, State Street Corp, Rock Point Advisors LLC, Voloridge Investment Management LLC, Royce & Associates LP, and IMA Wealth Inc..
View insider buying and selling activity for Evolent Health

Which major investors are buying Evolent Health stock?

EVH stock was acquired by a variety of institutional investors in the last quarter, including Great Lakes Advisors LLC, Fuller & Thaler Asset Management Inc., Voce Capital Management LLC, Great West Life Assurance Co. Can, JPMorgan Chase & Co., Sei Investments Co., Point72 Asset Management L.P., and GSA Capital Partners LLP. Company insiders that have bought Evolent Health stock in the last two years include Doug S Aron, Kenneth A Samet, Michael D'amato, and Seth Blackley.
View insider buying and selling activity for Evolent Health

How do I buy shares of Evolent Health?

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $15.19.

How big of a company is Evolent Health?

Evolent Health has a market capitalization of $1.30 billion and generates $846.38 million in revenue each year. The technology company earns $-301,970,000.00 in net income (profit) each year or ($0.91) on an earnings per share basis. Evolent Health employs 3,400 workers across the globe.

What is Evolent Health's official website?

The official website for Evolent Health is www.evolenthealth.com.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000 or via email at [email protected]

This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.